Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is highly rated in 25 conditions, according to our data. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Philip Ferrone is an Ophthalmologist in Elmhurst, New York. Dr. Ferrone is highly rated in 23 conditions, according to our data. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Coats Disease, and Vitrectomy.

Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is highly rated in 16 conditions, according to our data. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Geographic Atrophy, and Vitrectomy.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is highly rated in 10 conditions, according to our data. His top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is highly rated in 8 conditions, according to our data. His top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.

Dr. Jeffrey M. Liebmann is a Professor of Ophthalmology, Glaucoma Service Director, and Vice-Chair for the Department of Ophthalmology at Columbia University Medical Center.Dr. Jeffrey M. Liebmann graduated from Boston University School of Medicine, completed his ophthalmology residency at the State University of New York/Downstate Medical Center, and his glaucoma fellowship at the New York Eye and Ear Infirmary. Dr. Liebmann serves as Shirlee and Bernard Brown Professor, Vice-Chair, and Director of the Glaucoma Division of the Department Ophthalmology at Columbia University Medical Center. He is a fellow of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology and American College of Surgeons. Dr. Liebmann is currently Editor-in-Chief of Journal of Glaucoma, a member of the Board of Governors of the World Glaucoma Association and Board of Directors of The Glaucoma Foundation and Secretary-Treasurer of the New York Glaucoma Society. Dr. Liebmann is a past-President of the World Glaucoma Association, American Glaucoma Society, and the New York Society for Clinical Ophthalmology and was co-founder of the New York Glaucoma Research Institute, the American Glaucoma Society Foundation and ASCRS Glaucoma Day.In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Liebmann is Principal Investigator for the NIH African Descent and Glaucoma Evaluation Study (ADAGES) and Ocular Hypertension Treatment Study (OHTS III) at Columbia University and is the author and/or co-author of more than 1000 medical and scientific papers, book chapters, and abstracts. He has lectured widely in the United States and abroad on glaucoma diagnosis and management. His current main areas of research interest include the causes of glaucoma, glaucoma progression, glaucoma surgery, ocular imaging, and neuroprotection. Dr. Liebmann is highly rated in 7 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy.

Aakriti Shukla MD, MSc is an Associate Professor of Ophthalmology at CUMC and Attending Ophthalmologist at the New York Presbyterian Hospital. Dr. Shukla is a board-certified ophthalmologist and specializes in the medical and surgical management of glaucoma and cataracts. Her surgical expertise includes minimally invasive glaucoma surgery, traditional glaucoma surgery, glaucoma laser surgery, and cataract surgery.Dr. Shukla completed her undergraduate studies as a Trustee and Renaissance Scholar at the University of Southern California. She received her medical degree at Columbia University College of Physicians and Surgeons in New York City, where she was awarded a Doris Duke Clinical Research Fellowship and earned the Edith and Denton McKane Memorial Award for Outstanding Research in Ophthalmology. She completed her training as an ophthalmology resident and served as chief resident at Columbia University's Harkness Eye Institute. She earned a Master of Science degree at Columbia University’s Mailman School of Public Health in Patient-Oriented Research. She pursued further glaucoma subspecialty training at the Wilmer Eye Institute at Johns Hopkins University in Baltimore, MD. Prior to her appointment at Columbia University, she served as glaucoma faculty at the Wills Eye Hospital in Philadelphia, PA.Dr. Shukla has published numerous peer-reviewed articles, book chapters, and has been invited to speak nationally and internationally on her patient care and research. She serves on the editorial boards of Ophthalmology and Ophthalmology Glaucoma. She is continually inspired by her patients and aims to improve their quality of life while treating their glaucoma. Dr. Shukla is highly rated in 7 conditions, according to our data. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal.

Celso Tello is an Ophthalmologist in New York, New York. Dr. Tello is highly rated in 5 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Vitrectomy.

David Chu is an Ophthalmologist in Palisades Park, New Jersey. Dr. Chu is highly rated in 24 conditions, according to our data. His top areas of expertise are Uveitis, Scleritis, Interstitial Keratitis, Corneal Transplant, and Cataract Removal.

Nikola Ragusa is an Ophthalmologist in Astoria, New York. Dr. Ragusa is highly rated in 21 conditions, according to our data. His top areas of expertise are Glaucoma, Kallikrein Hypertension, Dry Eye Syndrome, Pterygium, and Corneal Transplant.

Nicholas Nissirios is an Ophthalmologist in Astoria, New York. Dr. Nissirios is highly rated in 18 conditions, according to our data. His top areas of expertise are Dry Eye Syndrome, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Eyelid Bump.

Marc Dinkin is an Ophthalmologist in New York, New York. Dr. Dinkin is highly rated in 15 conditions, according to our data. His top areas of expertise are Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, Papilledema, Stent Placement, and Vitrectomy. Dr. Dinkin is currently accepting new patients.

Louis Pasquale is an Ophthalmologist in New York, New York. Dr. Pasquale is highly rated in 10 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Hormone Replacement Therapy (HRT).

Anastasios Kanellopoulos is an Ophthalmologist in New York, New York. Dr. Kanellopoulos is highly rated in 7 conditions, according to our data. His top areas of expertise are Keratoconus, Astigmatism, Nearsightedness, Cataract Removal, and Corneal Transplant.

Nisha Chadha is an Ophthalmologist in New York, New York. Dr. Chadha is highly rated in 7 conditions, according to our data. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Cataract Removal.

Dan Reinstein is an Ophthalmologist in New York, New York. Dr. Reinstein is highly rated in 6 conditions, according to our data. His top areas of expertise are Nearsightedness, Astigmatism, Cataract, Vitrectomy, and Cataract Removal.

Joseph Panarelli is an Ophthalmologist in New York, New York. Dr. Panarelli is highly rated in 5 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Vitrectomy.

Marla Sultan is an Ophthalmologist in New York, New York. Dr. Sultan is highly rated in 1 condition, according to our data. Her top areas of expertise are Transthyretin Amyloid Cardiomyopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Macular Edema (DME).

Susan Fromer is an Ophthalmologist in New York, New York. Dr. Fromer is highly rated in 24 conditions, according to our data. Her top areas of expertise are Glaucoma, Kallikrein Hypertension, Allergic Conjunctivitis, and Meibomianitis.

Michael Engelbert, MD, PhD, a vitreoretinal surgeon and macular disease specialist, provides both medical care for age-related macular degeneration and diabetic eye disease as well as surgical management of macular disease and retinal detachment repair, including complex detachments from diabetes and after trauma or failed primary repair. He also specializes in secondary intraocular lens implantation after complicated cataract surgery. He is an internationally renowned expert on vitreous anatomy and vitreoretinal interface disorders, topics on which he lectures at home and abroad.Dr. Engelbert received his medical degree Magna Cum Laude from Ludwig-Maximilians-University in Munich, Germany, after which he dedicated himself several years to basic research in the study of endophthalmitis, a vision-threatening infection, that can occur after eye surgery. He earned a Ph.D. for this work and is considered a leader in this field.Before joining the residency program at Columbia University, Dr. Engelbert served his internship at Griffin Hospital, a Yale-affiliated center in Connecticut, where he was granted the Vincent D. DeLuca award for the best medical intern.Afterward, he was resident and chief resident in the Department of Ophthalmology of Columbia University’s College of Physicians and Surgeons at the Edward S. Harkness Eye Institute on the Columbia Presbyterian Medical Center Campus. Following his residency training, Dr. Engelbert was awarded a medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University.Dr. Engelbert is a member of The American Society of Retina Specialists (ASRS), The European Society of Vitreoretinal Specialists (EVRS), the Association for Research in Vision and Ophthalmology (ARVO), and The American Academy of Ophthalmology (AAO) and the prestigious Club Jules Gonin. He has published numerous papers on retinal disease, received several awards and has been granted permanent resident status in the United States in the category “outstanding scientist”. He serves as a reviewer for the premier journals in the field, including the Archives of Ophthalmology, Ophthalmology, Investigative Ophthalmology and Visual Sciences, Retina, Eye, and Graefe’s Archives of Clinical and Experimental Ophthalmology.He is a Research Assistant Professor at New York University and Clinical Instructor at NYU , where he is actively involved in instructing residents and fellows in the art of medical retina and retinal surgery, and provides care for an underserved population with often advanced disease requiring complex surgical intervention. Dr. Engelbert is highly rated in 18 conditions, according to our data. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.

Naomi Goldberg is an Ophthalmologist in New York, New York. Dr. Goldberg is highly rated in 16 conditions, according to our data. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, and Neuroretinitis.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is highly rated in 15 conditions, according to our data. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

Dr. Klancnik utilizes all forms of ophthalmic imaging including fluorescein angiography, indocyanine green angiography, as well as noninvasive forms of imaging such as spectral domain optical coherence tomography, autofluorescence photography, and ultrasonography.Dr. Klancnik is a magna cum laude graduate of Yale University. He earned his medical degree from Jefferson Medical College of Thomas Jefferson University and was elected to the Alpha Omega Alpha and Hobart Amory Hare honor medical societies. He completed his internship at the Lankenau Hospital and his ophthalmology residency at Wills Eye Hospital. He completed his medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University. He is an Assistant Professor of Clinical Ophthalmology at New York University School of Medicine.Dr. Klancnik is a member of numerous medical organizations including the American Academy of Ophthalmology, American Society of Retinal Specialists, and Association for Research in Vision and Ophthalmology. He is an author of numerous peer-reviewed journal articles and book chapters and has presented at scientific meetings nationally and internationally. He is active in numerous clinical trials as principle or sub-investigator and serves as a reviewer for several ophthalmology journals. Dr. Klancnik is highly rated in 13 conditions, according to our data. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion.

Kim Landzberg is an Ophthalmologist in Riverdale, New York. Dr. Landzberg is highly rated in 12 conditions, according to our data. Her top areas of expertise are Glaucoma, Cataract, Allergic Conjunctivitis, and Conjunctivitis (Pink Eye).

John Seedor is an Ophthalmologist in New York, New York. Dr. Seedor is highly rated in 11 conditions, according to our data. His top areas of expertise are Fuchs Dystrophy, Interstitial Keratitis, Corneal Dystrophy and Perceptive Deafness, Corneal Transplant, and Trabeculectomy.